[1] |
GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440): 2100-2132. doi: 10.1016/S0140-6736(24)00367-2
|
[2] |
胡亚男, 王秋童, 何凤蝶, 等. 中国成人自报结直肠癌患者生活方式研究[J]. 中华全科医学, 2023, 21(2): 279-282. doi: 10.16766/j.cnki.issn.1674-4152.002864HU Y N, WANG Q T, HE F D, et al. Study on the lifestyle of self-reported colorectal cancer patients among Chinese adults[J]. Chinese Journal of General Practice, 2023, 21(2): 279-282. doi: 10.16766/j.cnki.issn.1674-4152.002864
|
[3] |
HEMMINKI K, LI X J, FÖRSTI A, et al. Are population level familial risks and germline genetics meeting each other?[J]. Hered Cancer Clin Pract, 2023, 21(1): 3. DOI: 10.1186/s13053-023-00247-3.
|
[4] |
ZHANG X Y, ZHAO S W, SONG X B, et al. Inhibition effect of glycyrrhiza polysaccharide (GCP) on tumor growth through regulation of the gut microbiota composition[J]. J Pharmacol Sci, 2018, 137(4): 324-332. doi: 10.1016/j.jphs.2018.03.006
|
[5] |
SEPICH-POORE G D, ZITVOGEL L, STRAUSSMAN R, et al. The microbiome and human cancer[J]. Science, 2021, 371(6536): eabc4552. DOI: 10.1126/science.abc4552.
|
[6] |
NEAL M D, SODHI C P, JIA H P, et al. Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis[J]. J Biol Chem, 2012, 287(44): 37296-37308. doi: 10.1074/jbc.M112.375881
|
[7] |
孔程, 高仁元, 黄林生, 等. 肠道菌群及其代谢产物在结直肠癌中的研究进展[J]. 中华结直肠疾病电子杂志, 2017, 6(5): 421-426. doi: 10.3877/cma.j.issn.2095-3224.2017.05.015KONG C, GAO R Y, HUANG L S, et al. Research progress on gut microbiota and its metabolites in colorectal cancer[J]. Chin J Colorec Dis(Electron Ed), 2017, 6(5): 421-426. doi: 10.3877/cma.j.issn.2095-3224.2017.05.015
|
[8] |
QIAO C, WANG H Y, GUAN Q T, et al. Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer: insights and future perspectives[J]. Asian J Pharm Sci, 2022, 17(5): 613-629.
|
[9] |
EMDIN C A, KHERA A V, KATHIRESAN S. Mendelian randomization[J]. JAMA, 2017, 318(19): 1925-1925. doi: 10.1001/jama.2017.17219
|
[10] |
QIN Y W, HAVULINNA A S, LIU Y, et al. Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort[J]. Nat Genet, 2022, 54(2): 134-142. doi: 10.1038/s41588-021-00991-z
|
[11] |
BURGESS S, THOMPSON S G. Avoiding bias from weak instruments in Mendelian randomization studies[J]. Int J Epidemiol, 2011, 40(3): 755-764. doi: 10.1093/ije/dyr036
|
[12] |
于天琦, 徐文涛, 苏雅娜, 等. 孟德尔随机化研究基本原理, 方法和局限性[J]. 中国循证医学杂志, 2021, 21(10): 1227-1234.YU T Q, XU W T, SU Y N, et al. Basic principles, methods, and limitations of Mendelian randomization studies[J]. Chin J Evid-Based Med, 2021, 21(10): 1227-1234.
|
[13] |
ZHAO J, MING J S, HU X H, et al. Bayesian weighted Mendelian randomization for causal inference based on summary statistics[J]. Bioinformatics, 2019, 36(5): 1501-1508.
|
[14] |
TECER D, GÖǦÜŞ F, KALKANCI A, et al. Succinivibrionaceae is dominant family in fecal microbiota of Behçet's syndrome patients with uveitis[J]. PLoS One, 2020, 15(10): e0241691. DOI: 10.1371/journal.pone.0241691.
|
[15] |
SHIMIZU J, KUBOTA T, TAKADA E, et al. Relative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet's disease (210 characters)[J]. Clin Rheumatol, 2019, 38(5): 1437-1445. doi: 10.1007/s10067-018-04419-8
|
[16] |
PARKER B J, WEARSCH P A, VELOO A C M, et al. The Genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health[J]. Front Immunol, 2020, 11: 906. DOI: 10.3389/fimmu.2020.00906.
|
[17] |
BINDELS L B, PORPORATO P, DEWULF E M, et al. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver[J]. Br J Cancer, 2012, 107(8): 1337-1344. doi: 10.1038/bjc.2012.409
|
[18] |
IIDA N, DZUTSEV A, STEWART C A, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment[J]. Science, 2013, 342(6161): 967-970. doi: 10.1126/science.1240527
|
[19] |
李宗岩, 胡云霏, 赵昌会, 等. 肠道普雷沃菌与人类相关疾病关系研究进展[J]. 中国微生态学杂志, 2024, 36(1): 100-104.LI Z Y, HU Y F, ZHAO C H, et al. Research progress on the relationship between Prevotella and human-related diseases[J]. Chin J Microecol, 2024, 36(1): 100-104.
|
[20] |
ZHANG N, ZHANG R, JIANG L, et al. Inhibition of colorectal cancer in Alzheimer's disease is mediated by gut microbiota via induction of inflammatory tolerance[J]. Proc Natl Acad Sci U S A, 2024, 121(37): e2314337121. DOI: 10.1073/pnas.2314337121.
|
[21] |
HOU X Y, ZHANG P, DU H Z, et al. Prevotella contributes to individual response of FOLFOX in colon cancer[J]. Clin Transl Med, 2021, 11(9): e512. DOI: 10.1002/ctm2.512.
|
[22] |
PING X Y, WANG K, ZHANG J Y, et al. Psychroserpens luteolus sp. nov., isolated from Gelidium, reclassification of Ichthyenterobacterium magnum as Psychroserpens magnus comb. nov., Flavihalobacter algicola as Psychroserpens algicola comb. nov., Arcticiflavibacter luteus as Psychroserpens luteus comb. nov[J]. Arch Microbiol, 2022, 204(5): 279. DOI: 10.1007/s00203-022-02895-w.
|
[23] |
WONG C C, YU J. Gut microbiota in colorectal cancer development and therapy[J]. Nat Rev Clin Oncol, 2023, 20(7): 429-452. doi: 10.1038/s41571-023-00766-x
|